IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1276-1279 out of 1279.

<< < 47 | 48 | 49 | 50 | 51 | 52

Public Release: 25-May-2014
Nature Chemical Biology
Team validates potentially powerful new way to treat HER2-positive breast cancer
Scientists at Cold Spring Harbor Laboratory today reported a discovery that they hope will lead to the development of a powerful new way of treating an aggressive form of breast cancer called HER2-positive.
National Institutes of Health, American Diabetes Association, Brown University Seed Fund Cold Spring Harbor Laboratory Cancer Center

Contact: Peter Tarr
tarr@cshl.edu
917-435-5068
Cold Spring Harbor Laboratory

Public Release: 25-May-2014
Nature Medicine
Gene mutation found for aggressive form of pancreatic cancer
Researchers at the University of California, San Diego School of Medicine have identified a mutated gene common to adenosquamous carcinoma tumors -- the first known unique molecular signature for this rare, but particularly virulent, form of pancreatic cancer.
National Key Basic Research Program of China, National Natural Science Foundation of China

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 25-May-2014
Nature Cell Biology
Study identifies how signals trigger cancer cells to spread
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a signaling pathway in cancer cells that controls their ability to invade nearby tissues in a finely orchestrated manner. The findings offer insights into the early molecular events involved in metastasis, the deadly spread of cancer cells from primary tumor to other parts of the body. The study was published today in the online edition of Nature Cell Biology.
National Institutes of Health

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine

Public Release: 25-May-2014
Nature Medicine
Scientists discover potential new target for cancer immunotherapy
Myeloid-derived suppressor cells are found abundantly in the microenvironment around tumors. They suppress immune response and promote cancer progression. They've been hard to target, but MD Anderson researchers have identified a potential route of attack.
NIH/National Cancer Institute

Contact: Scott Merville
smerville@comcast.net
713-516-4855
University of Texas M. D. Anderson Cancer Center

Showing releases 1276-1279 out of 1279.

<< < 47 | 48 | 49 | 50 | 51 | 52

  Search News Releases

     

 

EurekAlert!